Contrast Associated Acute Kidney Injury and Mortality in Older Adults with Acute Coronary Syndrome: A Pooled Analysis of the FRASER and HULK Studies.

acute coronary syndrome contrast induced acute kidney injury mortality older patients percutaneous coronary intervention physical performance

Journal

Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588

Informations de publication

Date de publication:
16 May 2021
Historique:
received: 29 03 2021
revised: 26 04 2021
accepted: 27 04 2021
entrez: 2 6 2021
pubmed: 3 6 2021
medline: 3 6 2021
Statut: epublish

Résumé

Whether contrast-associated acute kidney injury (CA-AKI) is only a bystander or a risk factor for mortality in older patients undergoing percutaneous coronary intervention (PCI) is not well understood. Data from FRASER (NCT02386124) and HULK (NCT03021044) studies have been analysed. All patients enrolled underwent coronary angiography. The occurrence of CA-AKI was defined based on KDIGO criteria. The primary outcome of the study was to test the relation between CA-AKI and 3-month mortality. Overall, 870 older ACS adults were included in the analysis (mean age 78 ± 5 years; 28% females). CA-AKI occurred in 136 (16%) patients. At 3 months, 13 (9.6%) patients with CA-AKI died as compared with 13 (1.8%) without it (

Identifiants

pubmed: 34065642
pii: jcm10102151
doi: 10.3390/jcm10102151
pmc: PMC8156026
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Italian Health Ministry Ricerca Finalizzata 2018
ID : GR-2018-12367114

Références

J Am Coll Cardiol. 2004 Oct 6;44(7):1393-9
pubmed: 15464318
Heart. 2011 Nov;97(21):1753-7
pubmed: 21602521
Chest. 2020 Apr;157(4):751-752
pubmed: 32252919
Eur Heart J. 2019 Jan 7;40(2):87-165
pubmed: 30165437
J Am Coll Cardiol. 2016 Sep 27;68(13):1465-1473
pubmed: 27659469
J Cardiovasc Med (Hagerstown). 2017 Nov;18(11):908-915
pubmed: 28678146
Am Heart J. 2020 Nov;229:100-109
pubmed: 32822656
J Am Coll Cardiol. 2020 Mar 24;75(11):1321-1323
pubmed: 32192659
J Am Coll Cardiol. 2020 Mar 24;75(11):1311-1320
pubmed: 32192658
Eur Heart J. 2020 Nov 7;41(42):4103-4110
pubmed: 31891653
Clin J Am Soc Nephrol. 2009 Jul;4(7):1162-9
pubmed: 19556381
Nat Rev Nephrol. 2017 Apr;13(4):241-257
pubmed: 28239173
JAMA. 1996 May 15;275(19):1489-94
pubmed: 8622223
Acta Med Scand. 1954;150(4):297-302
pubmed: 13217726
Crit Care Med. 2013 Apr;41(4):1149
pubmed: 23528765
Cardiovasc Drugs Ther. 2019 Oct;33(5):523-532
pubmed: 31549262
Aging Clin Exp Res. 2017 Oct;29(5):895-903
pubmed: 27796963
Catheter Cardiovasc Interv. 2008 Sep 1;72(3):347-354
pubmed: 18729173
Am J Nephrol. 2009;29(2):136-44
pubmed: 18753738
JACC Cardiovasc Interv. 2014 Jan;7(1):1-9
pubmed: 24456715
BMC Cardiovasc Disord. 2018 May 21;18(1):98
pubmed: 29783928
J Am Coll Cardiol. 2019 Dec 10;74(23):2948-2950
pubmed: 31806139
Am J Med. 2019 Dec;132(12):e817-e826
pubmed: 31170374
Circulation. 2002 May 14;105(19):2259-64
pubmed: 12010907
Am J Med. 1989 Jun;86(6 Pt 1):649-52
pubmed: 2729314
Heart. 2020 Nov;106(21):1658-1664
pubmed: 32144189
J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1113-1119
pubmed: 31075167
N Engl J Med. 2019 Oct 10;381(15):1411-1421
pubmed: 31475795
J Am Coll Cardiol. 2018 May 8;71(18):2015-2040
pubmed: 29724356
J Cardiovasc Med (Hagerstown). 2008 Apr;9(4):375-81
pubmed: 18334892

Auteurs

Rita Pavasini (R)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Matteo Tebaldi (M)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Giulia Bugani (G)

U.O.C. Cardiologia, Ospedale Maggiore, Largo Nigrisoli 2, 40133 Bologna, Italy.

Elisabetta Tonet (E)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Roberta Campana (R)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Paolo Cimaglia (P)

Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Italy.

Elisa Maietti (E)

Department of Medical Science, University of Ferrara, 44121 Ferrara, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, 40127 Bologna, Italy.

Giovanni Grazzi (G)

Center of Sport and Exercise Sciences, University of Ferrara, 44121 Ferrara, Italy.

Graziella Pompei (G)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Gioele Fabbri (G)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Alessio Fiorio (A)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Andrea Rubboli (A)

Division of Cardiology, S. Maria Delle Croci Hospital, 48121 Ravenna, Italy.

Gianni Mazzoni (G)

Public Health Department, Azienda USL di Ferrara, 44121 Ferrara, Italy.

Francesco Vitali (F)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Matteo Serenelli (M)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Gianluca Campo (G)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.
Maria Cecilia Hospital, GVM Care & Research, 48033 Cotignola, Italy.

Simone Biscaglia (S)

Cardiovascular Institute, Azienda Ospedaliero-Universitaria di Ferrara, 44124 Ferrara, Italy.

Classifications MeSH